Quick Links |
 |
AntiMal is an integrated project comprising leading groups of researchers with expertise in malaria biology, chemotherapy and drug development. The aim is to exploit new scientific and political opportunities to secure the development of a portfolio of viable novel antimalarial drugs. This project is funded by the European Commission as part of its 6th Framework Programme and is coordinated by the Liverpool School of Tropical Medicine.